Date | Time | Source | Headline | Symbol | Company |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | Voting Rights and Denominator | EU:VGP | VGP NV |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | WORLDLINE : Q1 2024 revenue | EU:WLN | Worldline |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | Voting Rights and Denominator | LSE:0HM0 | Vgp Nv |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | IBA signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, US | TG:IOB | Ion Beam Applications SA |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations | BIT:1SAN | Sanofi |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions | LSE:ONWD | Onward Opportunities Limited |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations | EU:SAN | Sanofi |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | ArcelorMittal S.A.: ArcelorMittal reports first quarter 2024 results | TSXV:MTS | Metallis Resources Inc |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | WORLDLINE : Chiffre d’affaires T1 2024 | TG:WO6 | Worldline |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | Voting Rights and Denominator | TG:4V1 | VGP NV |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | WORLDLINE : Q1 2024 revenue | TG:WO6 | Worldline |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions | EU:ONWD | Onward Medical NV |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024 | EU:ARGX | Argen X SE |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | IBA signe un contrat avec Yale New Haven Health et Hartford HealthCare pour l’installation d’une solution de protonthérapie Proteus®ONE dans le Connecticut, aux États-Unis | TG:IOB | Ion Beam Applications SA |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | Increase of Share Capital in Connection with Realisation of the Staff Options Programme and Subscription Results | | |
05/02/2024 | 1:00AM | Business Wire | Elliptic Labs Launching on Transsion’s Infinix GT 20 Pro Smartphone | | |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations | EU:SAN | Sanofi |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | IBA signe un contrat avec Yale New Haven Health et Hartford HealthCare pour l’installation d’une solution de protonthérapie Proteus®ONE dans le Connecticut, aux États-Unis | EU:IBAB | Ion Beam Applications SA |
05/02/2024 | 1:00AM | Business Wire | TraWell Co. SpA Approves 2023 Financial Plan Showing Significant Improvement From 2022: Revenues €30.3M, EBITDA €10.2M (+14%), Net Profit €3.3M (+159%) | CHIX:TWL | Taylor Wimpey |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024 | NASDAQ:ARGX | argenx SE |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | IBA signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, US | EU:IBAB | Ion Beam Applications SA |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | WORLDLINE : Chiffre d’affaires T1 2024 | EU:WLN | Worldline |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | ArcelorMittal S.A.: ArcelorMittal reports first quarter 2024 results | EU:MT | ArcelorMittal |
05/02/2024 | 1:00AM | Business Wire | Infobip and Nokia Partner to Enable Developers to Build Wider Array of Telco Network Powered Applications Faster | | |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | ArcelorMittal S.A.: ArcelorMittal reports first quarter 2024 results | NYSE:MT | Arcelor Mittal New |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations | BIT:SANF | Sanofi |
05/02/2024 | 1:00AM | Business Wire | CDA DI TRAWELL CO. SPA APPROVA IL PROGETTO DI BILANCIO 2023 IN FORTE MIGLIORAMENTO RISPETTO AL 2022: RICAVI €30,3M EBITDA €10,2M (+14%) UTILE NETTO €3,3M (+159%) | CHIX:TWL | Taylor Wimpey |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations | TG:SNW | Sanofi |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | ForFarmers trading update Q1 2024: Like-for-like volume growth and strong increase operational profitability | EU:FFARM | Forfarmers NV |
05/02/2024 | 1:00AM | GlobeNewswire Inc. | ForFarmers trading update Q1 2024: Like-for-like volume growth and strong increase operational profitability | TG:5FF | Forfarmers NV |